Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Aug;57(8):4046-9.
doi: 10.1128/AAC.00663-13. Epub 2013 May 28.

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients

Yasuhiro Kawai  1 , Naoyuki Miyashita, Mika Kubo, Hiroto Akaike, Atsushi Kato, Yoko Nishizawa, Aki Saito, Eisuke Kondo, Hideto Teranishi, Tokio Wakabayashi, Satoko Ogita, Takaaki Tanaka, Kozo Kawasaki, Takashi Nakano, Kihei Terada, Kazunobu Ouchi
Affiliations
Multicenter Study

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients

Yasuhiro Kawai et al. Antimicrob Agents Chemother. 2013 Aug.

Abstract

We conducted nationwide surveillance to investigate regional differences in macrolide-resistant (MR) Mycoplasma pneumoniae strains in Japan. The prevalence of MR M. pneumoniae in pediatric patients gradually increased between 2008 and 2012. Although regional differences were observed, high levels of MR genes were detected in all seven surveillance areas throughout Japan and ranged in prevalence from 50% to 93%. These regional differences were closely related to the previous administration of macrolides.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Samples were collected from pediatric patients with acute respiratory tract infections who visited 65 institutions located in 7 areas of Japan (shaded areas). (A) Kyushu; (B) Chugoku; (C) Shikoku; (D) Kinki; (E) Tokai; (F) Kanto; (G) Hokkaido; (H) Hokuriku; (I) Koshinetsu; (J) Tohoku.
Fig 2
Fig 2
Year-by-year increases in the frequency of macrolide-resistant Mycoplasma pneumoniae cases from 2008 to 2012.
See this image and copyright information in PMC

References

    1. National Institute of Infectious Disease, Infectious Disease Surveillance Center 2013. Mycoplasma pneumoniae pneumonia. National Institute of Infectious Disease, Infectious Disease Surveillance, Tokyo, Japan: Center. http://idsc.nih.go.jp/idwr/kanja/weeklygraph/18myco.html
    1. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T. 2001. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol. Immunol. 45:617–620 - PubMed
    1. Matsuoka M, Narita M, Okazaki N, Ohya NH, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48:4624–4630 - PMC - PubMed
    1. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, Nakayama E, Sunagawa K, Ubukata K, Acute Respiratory Diseases Study Group 2008. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 52:348–350 - PMC - PubMed
    1. Morozumi M, Takahashi T, Ubukata K. 2010. Macrolide-resistant Mycoplasma pneumonia: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16:78–86 - PubMed

Publication types

MeSH terms